Botulinum Toxin Type A: Botox® Cosmetic and Dysport® Consent Form
  • Botulinum Toxin Type A: Botox® Cosmetic and Dysport® Consent Form

  • BOTOX® Cosmetic is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and Or procerus muscle activity in adult patients < 65 years of age.

    BOTOX® Cosmetic (onabotulinumtoxinA) for injection, is a sterile, vacuum-dried purified botulinum toxin type A. produced from fermentation of Hall strain Clostridium botulinum type A grown in a medium containing casein hydrolysate, glucose, and yeast extract, intended for intramuscular use- BOTOX® Cosmetic blocks neuromuscular transmission by binding to acceptor sites on motor nerve terminals. entering the nerve terminals, and inhibiting the release of acetylcholine- This inhibition occurs as the neurotoxin cleaves SNAP-25, a protein integral to the successful docking and release of acetylcholine from vesicles situated within nerve endings. When injected intramuscularly at therapeutic doses, BOTOX® Cosmetic produces partial chemical denervation of the muscle resulting in a localized reduction in muscle activity-

    Administration of BOTOX® Cosmetic is not recommended during pregnancy. There are no adequate and wellcontrolled studies of BOTOX® Cosmetic in pregnant womem It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when BOTOX® Cosmetic is administered to a nursing woman.

  • Powered by Jotform SignClear
  • DYSPORT™ (onabotu1inumtoxinA) is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients < 65 years of age.

    The effects of DYSPORT™ and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects- These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports ofdeath. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.

    DYSPORT™ is contraindicated in patients with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation- This product may contain trace amounts of cow's milk protein. Patients known to be allergic to cows milk protein should not be treated with DYSPORT™. DYSPORT™ is contraindicated for use in patients with infection at the proposed injection site(s).

    There are no adequate and well-controlled studies in pregnant women. DYSPORT™ should be used during pregnancy only ifthe potential benefit justifies the potential risk to the fetus. It is not known whether DYSPORT™ is excreted in human milk.

  • I authorize and direct * (provider name) to perform the following procedure of Botox® Cosmetic and Dysport® injections on * (patient name) for the treatment of (areas to be treated):

  • Powered by Jotform SignClear
  • Powered by Jotform SignClear
  • Should be Empty: